SENSEX NIFTY

Ranbaxy Laboratories

May 09, 2016 at 15:18 | Source: CNBC-TV18
Joint inspections with eight other regulators carried at six of Ranbaxys laboratories in Himachal Pradesh found discrepancies in testing, stability standards and expiry dates, among other standards.
May 05, 2016 at 20:47 | Source: CNBC-TV18
Malvinder and Shivinder Singh had sold their stake in Ranbaxy Laboratories to Daiichi way back in 2008, following which Daiichi-led Ranbaxy was forced to pay the US Department of Justice a sum of USD 500 million over non-compliance with US Food and Drug Administration's testing norms.
Apr 04, 2016 at 19:50 | Source: PTI
The Supreme Court today directed the government to reply in two weeks on a plea seeking cancellation of licence issued to Ranbaxy Laboratories Ltd forallegedly selling substandard drugs in India.
Mar 07, 2016 at 12:26 | Source: Reuters
Three years ago, Dinesh Thakur exposed how India's then largest drugmaker and his former employer, Ranbaxy Laboratories, failed to conduct proper safety and quality tests on drugs and lied to regulators about its procedures.
Jan 22, 2016 at 19:05 | Source: PTI
Last year in September, Sun Pharma and Strides Shasun (then Strides Arcolab) had inked a pact related to Ranbaxy's 'Solus' and 'Solus Care' divisions operating in the central nervous system (CNS) segment in India.
Oct 28, 2015 at 20:15 | Source: PTI
As per the information available on the USFDA website, Ohm Laboratories Inc, a unit of Ranbaxy Laboratories, which the company acquired last year, is recalling 10,85,095 boxes for being "Superpotent Drug: Out Of Specification".
Oct 11, 2015 at 11:27 | Source: PTI
The government is likely to commission a study soon to assess the impact of foreign direct investment in existing pharmaceutical companies in view of concerns expressed on the issue by a Parliamentary panel.
Oct 09, 2015 at 08:36 | Source: Moneycontrol.com
Sun Pharmaceutical Industries Ltd has informed BSE that the Company has withdrawn its appeal in the lawsuit filed by erstwhile Ranbaxy Laboratories Limited (Ranbaxy) in November 2014 in a US District Court against U.S. Food and Drug Administration (FDA).
Sep 24, 2015 at 16:42 | Source: CNBC-TV18
Prakash Diwan of prakashdiwan.in is of the view that Lupin may test Rs 2600-2700.
Sep 24, 2015 at 13:25 | Source: CNBC-TV18
Deepak Shenoy of capitalmind.in has a positive stance on Sun Pharmaceutical Industries and Strides Arcolab.
Messages on Ranbaxy Laboratories »

Market Statistician

Platinum Member

17113 Followers

Ranbaxy Labs  

Ranbaxy Laboratories has touched a 52-week high of Rs 557.00. At 15:14 hrs, the share was quoting at Rs 545.65, up Rs 2.50, or 0.46%. See more

3.15 PM Jul 8th 2014

Market Statistician

Platinum Member

17113 Followers

Ranbaxy Labs  

At 15:14 hrs, Ranbaxy Laboratories was trading at Rs 545.65 up 0.46%, with a huge increase in its volume of shares traded. Till now over 220,541 shares were traded as compared to its 5-day average of 106,981 shares.

3.15 PM Jul 8th 2014

Market Statistician

Platinum Member

17113 Followers

Ranbaxy Labs  

Ranbaxy Laboratories has touched a 52-week high of Rs 557.00. At 14:14 hrs, the share was quoting at Rs 550.20, up Rs 7.05, or 1.30%. See more

2.15 PM Jul 8th 2014

Market Statistician

Platinum Member

17113 Followers

Ranbaxy Labs  

Ranbaxy Laboratories has touched a 52-week high of Rs 557.00. At 13:14 hrs, the share was quoting at Rs 552.10, up Rs 8.95, or 1.65%. See more

1.15 PM Jul 8th 2014

Market Statistician

Platinum Member

17113 Followers

Ranbaxy Labs  

Ranbaxy Laboratories has touched a 52-week high of Rs 557.00. At 12:14 hrs, the share was quoting at Rs 550.65, up Rs 7.50, or 1.38%. See more

12.15 PM Jul 8th 2014

Market Statistician

Platinum Member

17113 Followers

Ranbaxy Labs  

Ranbaxy Laboratories has touched a 52-week high of Rs 557.00. At 11:14 hrs, the share was quoting at Rs 552.35, up Rs 9.20, or 1.69%. See more

11.15 AM Jul 8th 2014

Market Statistician

Platinum Member

17113 Followers

Ranbaxy Labs  

Ranbaxy Laboratories has touched a 52-week high of Rs 538.45. At 15:14 hrs, the share was quoting at Rs 533.20, down Rs 0.10, or 0.02%. See more

3.15 PM Jul 4th 2014

Market Statistician

Platinum Member

17113 Followers

Ranbaxy Labs  

Ranbaxy Laboratories has touched a 52-week high of Rs 538.45. At 14:14 hrs, the share was quoting at Rs 532.20, down Rs 1.10, or 0.21%. See more

2.15 PM Jul 4th 2014

Market Statistician

Platinum Member

17113 Followers

Ranbaxy Labs  

Ranbaxy Laboratories has touched a 52-week high of Rs 538.45. At 13:13 hrs, the share was quoting at Rs 531.20, down Rs 2.10, or 0.39%. See more

1.15 PM Jul 4th 2014

Market Statistician

Platinum Member

17113 Followers

Ranbaxy Labs  

Ranbaxy Laboratories has touched a 52-week high of Rs 538.45. At 12:14 hrs, the share was quoting at Rs 532.15, down Rs 1.15, or 0.22%. See more

12.15 PM Jul 4th 2014

News across the web »
Nov 07, 2015 at 02:30 | Source: FirstPost
Explore Moneycontrol

Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.